Showing results (211-220 of 323) with videos related to

Sort By:
Pageof 33
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2021
Mesoscale networks and corresponding transitions from self-assembly of block copolymersCheng-Yen Chang, Gkreti-Maria Manesi, Chih-Ying Yang, et al.
Oncotarget|November 22, 2014
WMJ-S-001, a novel aliphatic hydroxamate derivative, exhibits anti-angiogenic activities via Src-homology-2-domain-containing protein tyrosine phosphatase 1Yi-Fang Chang, Ya-Fen Hsu, Pei-Ting Chiu, et al.
Biochimica Et Biophysica Acta|March 8, 2011
p53 in trichostatin A induced C6 glioma cell deathYa-Fen Hsu, Joen-Rong Sheu, George Hsiao, et al.
Journal of Clinical Medicine|May 4, 2026
Anaerobes in Late-Onset Prosthetic Joint Infection (PJI) and Colorectal CarcinomaShi Ting Chiu, Mann Hong Tan, Seo Kiat Goh, et al.
Biochimica Et Biophysica Acta|April 16, 2013
Simvastatin induced HCT116 colorectal cancer cell apoptosis through p38MAPK-p53-survivin signaling cascadeHang-Lung Chang, Chih-Yu Chen, Ya-Fen Hsu, et al.
Journal of Personalized Medicine|February 25, 2022
Scabies Infestation and Risk of Acute Myocardial Infarction: A Population-Based Cohort StudyYao-Ping Ko, Pei-Yun Chen, Chung Y Hsu, et al.
ACS Chemical Neuroscience|September 8, 2020
Comparison of Pharmacological Properties between the Kappa Opioid Receptor Agonist Nalfurafine and 42B, Its 3-Dehydroxy Analogue: Disconnect between in Vitro Agonist Bias and in Vivo Pharmacological EffectsDanni Cao, Peng Huang, Yi-Ting Chiu, et al.
Thrombosis Journal|September 1, 2022
The trends in the incidence and thrombosis-related comorbidities of antiphospholipid syndrome: a 14-year nationwide population-based studyWei-Cheng Yao, Kam-Hang Leong, Lu-Ting Chiu, et al.
International Journal of Clinical Practice|February 16, 2021
Sex differences in long-term cardiovascular outcomes among patients with acute myocardial infarction: A population-based retrospective cohort studyShih-Sheng Chang, Shih-Yi Lin, Jung-Nien Lai, et al.
Experimental and Therapeutic Medicine|March 30, 2017
Naringenin inhibits migration of lung cancer cells via the inhibition of matrix metalloproteinases-2 and -9Huai-Lu Chang, Yuh-Ming Chang, Shih-Chan Lai, et al.
Pageof 33